16 results
6-K
CNTB
Connect Biopharma Holdings Ltd
12 Sep 23
Connect Biopharma Reports First Half 2023 Financial Results and Provides Business Update
4:47pm
and development activities, (4) expenses to develop our product candidates, including raw materials and supplies, product testing, manufacturing services
6-K
EX-99.1
CNTB
Connect Biopharma Holdings Ltd
23 Jun 23
House Lease Contract
4:31pm
, gunpowder, narcotics and intermediates, medical raw materials, drugs, etc., as well as products that must be produced only after the production permit
6-K
CNTB
Connect Biopharma Holdings Ltd
13 Sep 22
Connect Biopharma Reports First Half 2022 Financial Results
4:47pm
related expenses of personnel engaged in research and development activities, (4) expenses to develop our product candidates, including raw materials
20-F
EX-4.12
ap057k1
31 Mar 22
Annual report (foreign)
4:33pm
20-F
f8pxb
31 Mar 22
Annual report (foreign)
4:33pm
6-K
EX-99.2
xibdxe1
31 Aug 21
Index to the Unaudited Interim Condensed Consolidated Financial Statements
4:16pm
424B4
c11wn7secg48v
19 Mar 21
Prospectus supplement with pricing info
4:49pm
F-1/A
ejz3v2a7slxo5xxvb
18 Mar 21
Registration statement (foreign) (amended)
6:15am
F-1/A
tgd8uzflh8pdkvl6
12 Mar 21
Registration statement (foreign) (amended)
5:02pm
F-1
x1u 346qykz9
26 Feb 21
Registration statement (foreign)
4:56pm
F-1
EX-10.10
qxr07cu
26 Feb 21
Registration statement (foreign)
4:56pm
DRS/A
s93qtb1ton
26 Jan 21
Draft registration statement (amended)
12:00am
DRS
i8dk zo2hp3hi
17 Dec 20
Draft registration statement
12:00am
DRS
EX-10.7
ycvdmhl0
17 Dec 20
Draft registration statement
12:00am
- Prev
- 1
- Next